[HTML][HTML] Combination cancer therapy integrating T-cell immune checkpoint blockers and natural killer cell activation

J Li, Y Wei - Gene & Protein in Disease, 2024 - accscience.com
T-cell immune checkpoint blockers (ICBs) and natural killer (NK) cell activation have
emerged as promising strategies for cancer therapy in recent years. In this approach, ICBs …